DrugPatentWatch Database Preview
Watson Labs Teva Company Profile
» See Plans and Pricing
What is the competitive landscape for WATSON LABS TEVA, and what generic and branded alternatives to WATSON LABS TEVA drugs are available?
WATSON LABS TEVA has forty-nine approved drugs.
There are two tentative approvals on WATSON LABS TEVA drugs.
Summary for Watson Labs Teva
| US Patents: | 0 |
| Tradenames: | 43 |
| Ingredients: | 41 |
| NDAs: | 49 |
Drugs and US Patents for Watson Labs Teva
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs Teva | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209549-001 | Jul 27, 2018 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Labs Teva | VALSARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; valsartan | TABLET;ORAL | 091519-001 | Mar 21, 2013 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Labs Teva | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 203959-001 | Apr 18, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Watson Labs Teva | BUPRENORPHINE | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 204937-004 | Nov 20, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Watson Labs Teva | NORETHINDRONE AND ETHINYL ESTRADIOL (10/11) | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 071044-001 | Apr 1, 1988 | RX | No | No | Start Trial | Start Trial | |||||
| Watson Labs Teva | NAPROXEN | naproxen | TABLET;ORAL | 074163-003 | Feb 10, 1995 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Labs Teva | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 203959-003 | Apr 18, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
